STOCK TITAN

Vanguard disaggregates holdings; subsidiaries to report EXPO positions (EXPO)

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

The Vanguard Group filed Amendment No. 15 to a Schedule 13G/A reporting 0 shares of Exponent Inc. common stock. The filing states Vanguard underwent an internal realignment on January 12, 2026 and certain subsidiaries will report beneficial ownership separately in reliance on SEC Release No. 34-39538.

The amendment lists amount beneficially owned: 0 and percent of class: 0%, and is signed by Ashley Grim, Head of Global Fund Administration, dated 03/26/2026.

Positive

  • None.

Negative

  • None.

Insights

Vanguard disaggregated holdings; this filing shows no beneficial ownership of EXPO by the reporting entity.

The amendment cites an internal realignment effective January 12, 2026, and states that certain Vanguard subsidiaries or business divisions will report beneficial ownership separately under SEC Release No. 34-39538. The filing records 0 shares and 0% for the reporting entity.

Operationally, this is a reporting change tied to internal structure; cash‑flow treatment and subsidiary-level positions are not shown in this excerpt. Subsequent filings by the disaggregated entities may show their beneficial holdings.






Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G




Comment for Type of Reporting Person: On January 12, 2026, The Vanguard Group, Inc. went through an internal realignment. In accordance with SEC Release No. 34-39538 (January 12, 1998), certain subsidiaries or business divisions of subsidiaries of The Vanguard Group, Inc., that formerly had, or were deemed to have, beneficial ownership with The Vanguard Group, Inc., will report beneficial ownership separately (on a disaggregated basis) from The Vanguard Group, Inc. in reliance on such release. These subsidiaries and/or business divisions pursue the same investment strategies as previously pursued by The Vanguard Group, Inc. prior to the realignment. Further in accordance with SEC Release No. 34-39538 (January 12, 1998), The Vanguard Group, Inc. no longer has, or is deemed to have, beneficial ownership over securities beneficially owned by such subsidiaries and/or business divisions.


SCHEDULE 13G



The Vanguard Group
Signature:Ashley Grim
Name/Title:Head of Global Fund Administration
Date:03/26/2026

FAQ

What does Vanguard report for EXPO ownership in this Schedule 13G/A amendment?

The amendment reports 0 shares beneficially owned and 0% of Exponent Inc. common stock. It attributes the change to an internal realignment that caused disaggregated reporting by subsidiaries.

Why does Vanguard say ownership is now reported separately for EXPO?

Vanguard cites an internal realignment on January 12, 2026 and relies on SEC Release No. 34-39538 to report certain subsidiaries' beneficial ownership separately from The Vanguard Group, Inc.

Who signed the Schedule 13G/A amendment for Vanguard?

The filing is signed by Ashley Grim, Head of Global Fund Administration, with the signature date 03/26/2026. The signature certifies the amendment's disclosures.

Does this filing show any subsidiary holdings of EXPO after the realignment?

No; this amendment records 0 shares for The Vanguard Group reporting entity. Holdings by disaggregated subsidiaries are not shown in this excerpt and may appear in separate filings.

Does the amendment change Vanguard's voting or dispositive powers for EXPO shares?

The amendment lists sole and shared voting and dispositive powers as 0. It indicates the reporting entity has no voting or dispositive authority over EXPO common stock in this filing.
Exponent Inc

NASDAQ:EXPO

View EXPO Stock Overview

EXPO Rankings

EXPO Latest News

EXPO Latest SEC Filings

EXPO Stock Data

3.22B
48.63M
Engineering & Construction
Services-management Consulting Services
Link
United States
MENLO PARK